基于药品说明书和裁判文书的注射用帕瑞昔布用药风险点探索及应用

doi:10.19803/j.1672-8629.20210163

摘要/Abstract

摘要： 目的探讨注射用帕瑞昔布的用药风险点,提高临床合理使用注射用帕瑞昔布的安全性。方法以注射用帕瑞昔布药品说明书为基础,引入司法案例的裁决结果,整理出其用药风险点,以此回顾性评价某院使用该药的围手术期病历50份。结果从药品说明书和裁判文书2个角度分别制定注射用帕瑞昔布的用药风险点评估表。注射用帕瑞昔布不合理用药主要表现为：禁忌症用药、配伍禁忌和用药天数过长等。结论以药品说明书为基础,引入司法案例的裁决结果,能更加全面、科学地总结出临床用药的风险点,搭建出更加严密的用药安全网。

关键词: 帕瑞昔布, 注射给药, 药品说明书, 裁判文书

Abstract: Objective To explore the risks of parecoxib for injection and improve the safety of medications with this drug. Methods Based on drug instructions of parecoxib and the ruling results of judicial cases, the potential risks of parecoxib were explored. Fifty cases of patients who had used this drug perioperatively were retrospectively evaluated. Results Risk assessment tables of parecoxib were formulated in line with drug instructions and judgment documents. The three main problems with the usage of parecoxib included contraindications, incompatibility and overuse. Conclusion Based on drug instructions and court verdicts, clinicians can have a better knowledge of risks of medications with parecoxib in order to ensure safe drug use.

Key words: parecoxib, injection, drug instructions, judgment documents

中图分类号:

R969.3

赵建彬, 黄玉玲. 基于药品说明书和裁判文书的注射用帕瑞昔布用药风险点探索及应用[J]. 中国药物警戒, 2022, 19(11): 1250-1253.

ZHAO Jianbin, HUANG Yuling. Risks and applications of parecoxib for injection based on drug instructions and judgment documents[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1250-1253.

参考文献

[1] HUI L, YUAN Y, WANG ZH, et al.Clinical efficacy of parecoxib sodium in patients with hepatocellular carcinoma after hepatectomy[J]. Journal of Pharmaceutical Practice(药学实践杂志), 2017, 35(1): 73-74,81.
[2] Aspect of pharmaceutical affairs. Yesterday added newcomer, cloth products market pattern quietly[EB/OL]. (2019-10-25)[2020-01-20].https://mp.weixin.qq.com/s/lr0fce464oXn6mVMtCxETg.
[3] WANG RR, RAO YF, YU Z, et al.Retrospective study on the use of nonsteroidal anti-inflammatory drugs during perioperative period[J]. Chinese Journal of Pharmacy(中国药学杂志), 2019, 54(13): 1104-1108.
[4] FENG YN, LIU XX, LI YH, et al.Pharmacovigilance in medical institutions under the new Drug Administration Law[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(9): 572-573,582.
[5] REN XD, ZHANG L, WEI YX, et al.Ambivalence of drug instructions and countermeasures[J]. China Pharmacy(中国药房), 2015, 26(22): 3150-3152.
[6] China Judicial Process Information Online. Provisions on People's Courts Publishing Judgments on the Internet[EB/OL]. (2016-08-31)[2021-03-01]. https://splcgk.court.gov.cn/gzfwww/sfjs/details?id=8b658418b1c14cf5beceb2eb815ce87f.
[7] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2021-03-01]. https://wenshu.court.gov.cn/.
[8] LIU L, FAN Z.Clinical application of drug instruction from the perspective of law[J]. Chinese Journal of Clinical Pharmacology(中国临床药理学杂志), 2020, 36(4): 456-457, 461.
[9] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2016-10-31]. https://wenshu.court.gov.cn/.
[10] The Supreme People's Court of the People's Republic of China. China Judgements Online[EB/OL].[2019-03-05]. https://wenshu.court.gov.cn/.
[11] XU JG.A general consensus on the management of postoperative pain in adults[J].Journal of Clinical Anesthesiology(临床麻醉学杂志), 2017, 33(9): 911-917.
[12] Guangdong Pharmaceutical Society.Guidelines for postoperative pain management of clinical pharmacists[J]. Today Pharmacy(今日药学), 2019, 29(4): 217-227.
[13] National Health and Family Planning Commission Rational Drug Use Expert Committee, Chinese Pharmacists Association. Guidelines for Rational Drug Use in Coronary Heart Disease(冠心病合理用药指南)[M]. Beijing : People's Health Publishing House, 2016.
[14] DENG DY, SU YX.Empirical prospect and ideal construction of“judgment-centered”- from the analytical perspective of 2185 criminal judgment documents[J]. Sun Yat-sen University Law Review(中山大学法律评论), 2018 (2):135-152.
[15] YU Y, LIU DL, CHEN F, et al.Analysis and intervention of unreasonable medical order in endocrine inpatients[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2020, 17(12): 921-925,933.
[16] GUO F, LI T, SUN RJ, et al.The effect of pharmaceutical intervention on the use of second class psychotropic drugs in a psychiatric hospital[J].Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(9): 550-554, 560.
[17] CHEN HM, JIA HF, LYU LY, et al.Effects of dexmedetomidine combined with parecoxib on postoperative inflammatory factors and intestinal mucosal barrier function in elderly patients with severe pancreatitis[J]. Chinese Journal of Gerontology(中国老年学), 2019, 39(4): 83-85.
[18] ZHANG YQ, SONG HJ, WANG ZD.Effect of somatostatin and esomeprazole on the treatment of upper gastrointestinal bleeding[J]. Modern Medicine and Clinical Practice(现代药物与临床), 2017, 32(3): 455-459.
[19] YUAN W, CHEN X, LIU Y, et al.Evaluation of safety of Agkistrodon agkistrodon hemagglutinase in otolaryngology head and neck surgery[J].Chinese Journal of Medical Guide(中国医药导刊), 2015, 17(4): 366-368.
[20] LI CT, HU XD, CHEN G, et al.Comparison of hemostatic efficacy and safety of Agkistrodon agkistrodon hemagglutinase for injection in hepatectomy[J]. Chongqing Medical Science(重庆医学), 2017, 46(8): 1070-1072, 1075.